Technical Analysis for MRK - Merck & Company, Inc.

Grade Last Price % Change Price Change
grade A 88.75 0.09% 0.08
MRK closed up 0.09 percent on Thursday, December 5, 2019, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical MRK trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
New 52 Week Closing High Bullish 0.09%
Expansion Breakout Bullish Swing Setup 0.09%
New 52 Week High Strength 0.09%
Upper Bollinger Band Walk Strength 0.09%
Above Upper BB Strength 0.09%

Older signals for MRK ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Medicine Health Life Sciences Pharmaceutical Industry Diabetes Medication Obesity Antibiotics Animal Health Products Cac 40 Vaccine Respiratory Diseases Sanofi Drug Wholesalers Health Solutions Over The Counter Products Food Chain Foot Care Products Luminex Corporation

Is MRK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Indicators
Indicator Value
52 Week High 88.79
52 Week Low 70.89
Average Volume 7,813,816
200-Day Moving Average 82.65
50-Day Moving Average 84.57
20-Day Moving Average 85.64
10-Day Moving Average 87.06
Average True Range 1.28
ADX 15.81
+DI 26.03
-DI 14.34
Chandelier Exit (Long, 3 ATRs ) 84.96
Chandelier Exit (Short, 3 ATRs ) 86.50
Upper Bollinger Band 89.06
Lower Bollinger Band 82.22
Percent B (%b) 0.95
BandWidth 7.99
MACD Line 1.10
MACD Signal Line 0.76
MACD Histogram 0.3348
Fundamentals Value
Market Cap 242.05 Billion
Num Shares 2.73 Billion
EPS 1.85
Price-to-Earnings (P/E) Ratio 47.97
Price-to-Sales 4.23
Price-to-Book 4.28
PEG Ratio 2.67
Dividend 1.88
Dividend Yield 2.12%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 89.98
Resistance 3 (R3) 89.86 89.32 89.78
Resistance 2 (R2) 89.32 89.01 89.39 89.71
Resistance 1 (R1) 89.04 88.82 89.18 89.16 89.64
Pivot Point 88.50 88.50 88.58 88.57 88.50
Support 1 (S1) 88.22 88.19 88.36 88.34 87.86
Support 2 (S2) 87.68 88.00 87.75 87.79
Support 3 (S3) 87.40 87.68 87.73
Support 4 (S4) 87.52